APA (7th ed.) Citation

X, W., PM, G., MN, P., K, C., KA, S., C, S., . . . H, Y. (2013). Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 27(7), 2713. https://doi.org/10.1096/fj.12-222992

Chicago Style (17th ed.) Citation

X, Wang, Grace PM, Pham MN, Cheng K, Strand KA, Smith C, Li J, Watkins LR, and Yin H. "Rifampin Inhibits Toll-like Receptor 4 Signaling by Targeting Myeloid Differentiation Protein 2 and Attenuates Neuropathic Pain." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 27, no. 7 (2013): 2713. https://doi.org/10.1096/fj.12-222992.

MLA (9th ed.) Citation

X, Wang, et al. "Rifampin Inhibits Toll-like Receptor 4 Signaling by Targeting Myeloid Differentiation Protein 2 and Attenuates Neuropathic Pain." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 27, no. 7, 2013, p. 2713, https://doi.org/10.1096/fj.12-222992.